PubRank

June Tordoff

Author PubWeight™ 20.89‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A 3-dimensional view of access to licensed and subsidized medicines under single-payer systems in the US, the UK, Australia and New Zealand. Pharmacoeconomics 2012 2.14
2 A systematic review and meta-analysis of pharmacist-led fee-for-services medication review. Br J Clin Pharmacol 2014 1.57
3 Continuation of proton pump inhibitors from hospital to community. Pharm World Sci 2006 1.39
4 Pediatric licensing status and the availability of suitable formulations for new medical entities approved in the United States between 1998 and 2002. J Clin Pharmacol 2006 1.19
5 Effect of the pediatric exclusivity provision on children's access to medicines. Br J Clin Pharmacol 2005 1.19
6 Trends in accessibility to medicines for children in New Zealand: 1998-2002. Br J Clin Pharmacol 2004 1.11
7 Changes in availability of paediatric medicines in Australia between 1998 and 2002. Br J Clin Pharmacol 2005 1.10
8 Examining the first year of Medicines Use Review services provided by pharmacists in New Zealand: 2008. N Z Med J 2009 0.99
9 Establishing a baseline for the monitoring of medicines availability for children in the UK: 1998-2002. Br J Clin Pharmacol 2006 0.92
10 Access to prescribing information for paediatric medicines in the USA: post-modernization. Br J Clin Pharmacol 2008 0.91
11 General practitioners' perceptions of pharmacists' new services in New Zealand. Int J Clin Pharm 2012 0.90
12 The impact of pharmaceutical cost containment policies on the range of medicines available and subsidized in Finland and New Zealand. Value Health 2009 0.85
13 Documenting pharmacist's clinical interventions in New Zealand hospitals. Pharm World Sci 2007 0.82
14 General practitioners' views of pharmacists' current and potential contributions to medication review and prescribing in New Zealand. J Prim Health Care 2013 0.81
15 Pharmacists' performance of clinical interventions during adherence support medication reviews. Res Social Adm Pharm 2013 0.81
16 Key informants' perceptions of how pharmac operates in New Zealand. Int J Technol Assess Health Care 2012 0.77
17 Retrospective examination of selected outcomes of Medicines Use Review (MUR) services in New Zealand. Int J Clin Pharm 2014 0.77
18 Health professionals: how do they assess new medicines? Pharm World Sci 2005 0.76
19 Using an Electronic Decision Support Tool to Reduce Inappropriate Polypharmacy and Optimize Medicines: Rationale and Methods. JMIR Res Protoc 2016 0.75
20 The authors' reply to wonder and milne: "comparing subsidized access to medicines across payer systems". Pharmacoeconomics 2013 0.75
21 Quality use of medicines activities: QSUM and PHARMAC. N Z Med J 2005 0.75
22 Access to children's medicines in the United Kingdom, Australia and New Zealand in 1998, 2002 and 2007. Pharm World Sci 2010 0.75
23 Older people's attitudes towards their regular medicines. J Prim Health Care 2013 0.75
24 Do Residents Need All Their Medications? A Cross-Sectional Survey of RNs' Views on Deprescribing and the Role of Clinical Pharmacists. J Gerontol Nurs 2017 0.75